Evaluation of the Selected Parameters of Inflammation in Patients with Haemorrhagic Stroke
DOI:
https://doi.org/10.15225/PNN.2023.12.1.1Keywords
clinical status, functional capacity, haemorrhagic stroke, inflammationAbstract
Introduction. In the acute phase of stroke, the development of inflammation within the stroke focus can be observed.
Therefore, in response to the inflammatory process in the brain, an inflammatory reaction occurs in the peripheral blood.
Aim. The aim of the study was to assess the parameters of inflammation in peripheral blood in a group of patients
with haemorrhagic stroke.
Material and Methods. The study included 64 patients with haemorrhagic stroke hospitalized at the Stroke Centre
of the Department of Neurology, University Hospital no. 1 in Bydgoszcz. The type and location of the stroke were
verified by a head CT scan performed on the first day of hospitalization. On the first day of stroke, together with
routine laboratory tests, the level of CRP1, WBC1, PCT, OB and fibrinogen1 was determined. CRP2, WBC2 and
fibrinogen2 levels were repeated on the 14th day of stroke. Patients with infection were excluded from the study.
Non-parametric statistical methods were used in the analysis: the Mann–Whitney test, the Kruskal–Wallis test and
the Spearman correlation coefficient.
Results. Subcortical localization of the haemorrhagic focus was found in the majority of patients. Both baseline
and control CRP and WBC values were outside the laboratory range. There were no statistically significant differences
between the baseline and control CRP and WBC values, while the control fibrinogen level was significantly higher
than baseline (p<0.041). Patients who died and/or those with impaired consciousness had statistically significantly
higher values of inflammatory parameters (except OB, PCT and FIBR1) compared to patients who survived and
were conscious.
Conclusions. In our study, we observed a significant increase in fibrinogen levels 14 days after the onset of the stroke.
In addition, the control level of fibrinogen correlated with the size of the haemorrhagic focus and the clinical condition
of the patients. Further research is needed in this area. (JNNN 2023;12(1):3–8)
References
Lanas F., Seron P. Facing the stroke burden worldwide. Lancet Glob Health. 2021;9(3):e235–e236.
Yan J., Hui R., Wang D. Elevated C-reactive protein levels predict worsening prognosis in Chinese patients with first-onset stroke. Front Med China. 2009;3:30–35.
McColl B.W., Allan S.M., Rothwell N.J. Systemic inflammation and stroke: aetiology, pathology and targets for therapy. Biochem Soc Trans. 2007;35(Pt 5):1163–1165.
den Hertog H.M., van Rossum J.A., van der Worp H.B. et al. C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol. 2009;256(12):2003–2008.
Smith C.J., Emsley H.C., Vail A. et al. Variability of the systemic acute phase response after ischemic stroke. J Neurol Sci. 2006;251(1–2):77–81.
Gill R., Kemp J.A., Sabin C., Pepys M.B. Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats. J Cereb Blood Flow Metab. 2004;24(11):1214–1218.
Bos M.J., Schipper C.M., Koudstaal P.J., Witteman J.C., Hofman A., Breteler M.M. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation. 2006;114(15):1591–1598.
Rost N.S., Wolf P.A., Kase C.S. et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32(11):2575–2579.
Montaner J., Fernandez-Cadenas I., Molina C.A. et al. Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke. 2006;37(5):1205–1210.
Di Napoli M., Papa F., Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke. 2001;32(1):133–138.
Roudbary S.A., Saadat F., Forghanparast K., Sohrabnejad R. Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke. Acta Med Iran. 2011;49(3):149–152.
Whiteley W., Jackson C., Lewis S. et al. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med. 2009;6(9):e1000145.
Wang J., Doré S. Inflammation after intracerebral haemorrhage. J Cereb Blood Flow Metab. 2007;27(5):894–908.
Sturgeon J.D., Folsom A.R., Longstreth W.T. Jr, Shahar E., Rosamond W.D., Cushman M. Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort. Stroke. 2008;39(8):2268–2273.
Peycheva M., Deneva T., Zahariev Z. The role of fibrinogen in acute ischaemic stroke. Neurol Neurochir Pol. 2021;55(1):74–80.
Mehta V., Sharma A., Jyoti D. et al. Fibrinogen as a Predictor of Early Neurological Deterioration in Acute Ischemic Stroke — Evidence From the Indian Population. J Cent Nerv Syst Dis. 2023;15:11795735231156349.
Sato S., Iso H., Noda H. et al. Plasma fibrinogen concentrations and risk of stroke and its subtypes among Japanese men and women. Stroke. 2006;37(10):2488–2492.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 455
Number of citations: 0